Company / Current Assets
Ernexa Therapeutics Inc. Current Assets History
FY2014-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Assets
$3.1M
FY2025
5-year range
$1.7M / $9.6M
FY2021-FY2025
Trend
+33.2%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Current Assets has fluctuated over the past 10 years, ranging from $2M in FY2020 to $15M in FY2014.
Based on SEC 10-K filings.
$3M in FY2025 with a 10-year CAGR of -10.1%.
Declined from $10M to $3M over the past 2 years.
Current Assets over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- +12.7%
- 10-Year CAGR
- -10.1%
Key checks
Key Insights
- 5-year CAGR of +12.7%, indicating consistent growth.
- In FY2025, current assets increased 33.2% year-over-year.
- Peak current assets was recorded in FY2014.
- Lowest current assets in the period was in FY2020.
Company context
Key Data Points
- Altman Z-Score -8.07 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current AssetsValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $3.1M | +33.2% |
| FY2024 | $2.4M | -75.5% |
| FY2023 | $9.6M | +456.8% |
| FY2020 | $1.7M | -71.6% |
| FY2019 | $6.1M | -10.5% |
| FY2018 | $6.8M | -29.6% |
| FY2017 | $9.6M | -9.6% |
| FY2016 | $10.7M | +17.0% |
| FY2015 | $9.1M | -38.7% |
| FY2014 | $14.9M | +87.8% |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026